Active Ingredient(s): Epinastine
FDA Approved: * October 16, 2003
Pharm Company: * ALLERGAN
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Elestat Overview

Epinastine (brand names Alesion, Elestat, Purivist, Relestat) is a second-generation antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is produced by Allergan and marketed by Inspire in the United States.[1] It is highly selective for the H1 receptor and does not cross the blood-brain-barrier.[2] It was patented in 1980 and came into medical use in 1994.[3] References .mw-parser-output .refl...

Read more Elestat Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Epinastine

Recent Elestat Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 0.05%
  • Solution/drops: 0.05%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Elestat: (1 result)

Sorted by National Drug Code
  • 0023-9201 Elestat .5 mg/ml Ophthalmic Solution/ Drops by Allergan, Inc.

Other drugs which contain Epinastine or a similar ingredient: (1 result)